449 related articles for article (PubMed ID: 36683420)
1. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
[No Abstract] [Full Text] [Related]
2. The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study.
Korayem GB; Aljuhani O; Altebainawi AF; Shaya AIA; Alnajjar LI; Alissa A; Aldhaeefi M; Kensara R; Al Muqati H; Alhuwahmel A; Alhuthaili O; Vishwakarma R; Aldardeer N; Eljaaly K; Alharbi A; Harbi SA; Katheri AA; Bekairy AMA; Aljedai A; Al Sulaiman K
Int J Infect Dis; 2022 Sep; 122():252-259. PubMed ID: 35605948
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
[TBL] [Abstract][Full Text] [Related]
4. The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study.
Aljuhani O; Al Sulaiman K; B Korayem G; Alharbi A; Altebainawi AF; Aldkheel SA; Alotaibi SG; Vishwakarma R; Alshareef H; Alsohimi S; AlFaifi M; Al Shaya A; Alhaidal HA; Alsubaie RM; Alrashidi H; Albarqi KJ; Alangari DT; Alanazi RM; Altaher NM; Al-Dorzi HM
Ren Fail; 2023; 45(2):2268213. PubMed ID: 37870869
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K
J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493
[TBL] [Abstract][Full Text] [Related]
6. When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; AlFaifi M; Nahari M; Almagthali A; Thabit AK; Alhajaji R; Alharbi R; Kahtani K; Alenazi AA; Alharbi A; Alghwainm MM; Alotaibi SM; Alghamdi YS; Alotaibi S; Alonazi SH; Almutairi JM; Vishwakarma R
J Infect Public Health; 2023 Sep; 16(9):1492-1499. PubMed ID: 37355406
[TBL] [Abstract][Full Text] [Related]
7. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
Gupta S; Wang W; Hayek SS; Chan L; Mathews KS; Melamed ML; Brenner SK; Leonberg-Yoo A; Schenck EJ; Radbel J; Reiser J; Bansal A; Srivastava A; Zhou Y; Finkel D; Green A; Mallappallil M; Faugno AJ; Zhang J; Velez JCQ; Shaefi S; Parikh CR; Charytan DM; Athavale AM; Friedman AN; Redfern RE; Short SAP; Correa S; Pokharel KK; Admon AJ; Donnelly JP; Gershengorn HB; Douin DJ; Semler MW; Hernán MA; Leaf DE;
JAMA Intern Med; 2021 Jan; 181(1):41-51. PubMed ID: 33080002
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study.
Aljuhani O; Korayem GB; Altebainawi AF; AlMohammady D; Alfahed A; Altebainawi EF; Aldhaeefi M; Badreldin HA; Vishwakarma R; Almutairi FE; Alenazi AA; Alsulaiman T; Alqahtani RA; Al Dhahri F; Aldardeer N; Alenazi AO; Al Harbi S; Kensara R; Alalawi M; Al Sulaiman K
BMC Infect Dis; 2024 Feb; 24(1):189. PubMed ID: 38350878
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
Al Sulaiman K; Aljuhani O; Al Dossari M; Alshahrani A; Alharbi A; Algarni R; Al Jeraisy M; Al Harbi S; Al Katheri A; Al Eidan F; Al Bekairy AM; Al Qahtani N; Al Muqrin M; Vishwakarma R; Al Ghamdi G
Crit Care; 2021 Jun; 25(1):223. PubMed ID: 34193235
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study.
Al Sulaiman K; Aljuhani O; Al Shaya AI; Kharbosh A; Kensara R; Al Guwairy A; Alharbi A; Algarni R; Al Harbi S; Vishwakarma R; Korayem GB
Crit Care; 2021 Oct; 25(1):363. PubMed ID: 34663411
[TBL] [Abstract][Full Text] [Related]
11. The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study.
Aljuhani O; Al Sulaiman K; Korayem GB; Altebainawi AF; Alsohimi S; Alqahtani R; Alfaifi S; Alharbi A; AlKhayrat A; Hattan A; Albassam M; Almohammed OA; Alkeraidees A; Alonazi DA; Alsalman WF; Aldamegh G; Alshahrani R; Vishwakarma R
Sci Rep; 2024 Feb; 14(1):3037. PubMed ID: 38321099
[TBL] [Abstract][Full Text] [Related]
12. Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study.
Al Sulaiman K; Korayem GB; Eljaaly K; Altebainawi AF; Al Harbi O; Badreldin HA; Al Harthi A; Al Yousif G; Vishwakarma R; Albelwi S; Almutairi R; Almousa M; Alghamdi R; Alhubaishi A; Alissa A; Alharbi A; Algarni R; Al Homaid S; Al Qahtani K; Akhani N; Al Atassi A; Al Ghamdi G; Aljuhani O
Sci Rep; 2022 Jun; 12(1):9766. PubMed ID: 35697822
[TBL] [Abstract][Full Text] [Related]
13. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study.
Al Sulaiman K; Aljuhani O; Al Aamer K; Al Shaya O; Al Shaya A; Alsaeedi AS; Alhubaishi A; Altebainawi AF; Al Harthi A; Albelwi S; Almutairi R; Alsubaie N; Alsallum A; Korayem GB; Alfahed A; Kensara R; Altebainawi EF; Alenezi RS; Alsulaiman T; Al Enazi H; Vishwakarma R; Al Dabbagh T; Bakhsh U; Al Ghamdi G
J Intensive Care Med; 2022 Feb; 37(2):248-257. PubMed ID: 34757869
[No Abstract] [Full Text] [Related]
14. Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.
Kensara R; Aljuhani O; Korayem GB; Alkofide H; Almohareb SN; Alosaimi YS; Altebainawi AF; Bin Saleh K; Andas NA; Harbi SA; Harthi AFA; Ashkan U; Alghamdi R; Badreldin HA; Hafiz A; AlFaifi M; Alqahtani RA; Vishwakarma R; Alenazi AA; Alalawi M; Mahboob R; Alfouzan RA; Al Tuhayni LB; Qahtani NA; Sulaiman KA
Clin Appl Thromb Hemost; 2023; 29():10760296231156178. PubMed ID: 36789786
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Tocilizumab in Management of COVID-19 Patients Admitted to Intensive Care Units: A Multicenter Retrospective Cohort Study.
Ibrahem HY; Aly DH; Warda AEA; Farahat RA; Youssef RM; Abdelhamid MH; Goud HA; Mohamed RR; Eldien MAYN; Alotaibi FO; Alzarea AI; Alanazi AS; Eisa NM; Refaee AS
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676678
[No Abstract] [Full Text] [Related]
16. Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study.
Al Harbi S; Kensara R; Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Vishwakarma R; Alenazi AM; Almutairi A; Alshaya O; Alraddadi S; Al Sulaiman T; Aldakkan L; Mahboob R; Alaamer K; Alissa A; Hafiz A; Aldhayyan N; Althewaibi S; Alenezi F; Alkhotani NY; Alghamdi SA; Alenazi AA; Al Sulaiman K
Clin Appl Thromb Hemost; 2022; 28():10760296221103864. PubMed ID: 35658686
[TBL] [Abstract][Full Text] [Related]
17. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
Hermine O; Mariette X; Tharaux PL; Resche-Rigon M; Porcher R; Ravaud P;
JAMA Intern Med; 2021 Jan; 181(1):32-40. PubMed ID: 33080017
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics.
Elhazmi A; Rabie AA; Al-Omari A; Mufti HN; Sallam H; Alshahrani MS; Mady A; Alghamdi A; Altalaq A; Azzam MH; Sindi A; Kharaba A; Al-Aseri ZA; Almekhlafi GA; Tashkandi W; Alajmi SA; Faqihi F; Alharthy A; Al-Tawfiq JA; Melibari RG; Arabi YM
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983304
[TBL] [Abstract][Full Text] [Related]
19. The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; Al Harbi S; Al Shaya A; Badreldin HA; Kensara R; Alharthi AF; Alghamdi J; Alawad A; Alotaibi R; Kharbosh A; Al Muqati H; Alhuwahmel A; Almusallam M; Albarrak G; Al Sulaihim I; Alanazi B; Al-Dosari BS; Vishwakarma R; Alsaeedi AS; Al Ghamdi G; Alkofide H; Al-Dorzi HM
Front Public Health; 2022; 10():877944. PubMed ID: 36033795
[TBL] [Abstract][Full Text] [Related]
20. Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study.
Al Sulaiman K; Aljuhani O; Bin Salah K; Korayem GB; Eljaaly K; Al Essa M; Kharbosh A; Al Harbi F; Abuzaid M; Al Bilal S; Almagthali A; Alsohemi S; Alshabasy A; Noureldeen H; Aboudeif M; Alshehri A; Vishwakarma R
J Crit Care; 2021 Dec; 66():44-51. PubMed ID: 34438133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
